共 5 条
- [1] Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study[J] . Peter A. LeWitt,Kelly E. Lyons,Rajesh Pahwa.Neurology . 2007 (16)
- [2] Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications[J] . C Warren Olanow,Jose A Obeso,Fabrizio Stocchi.Lancet Neurology . 2006 (8)
- [3] Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges[J] . ReginaKatzenschlager,AndrewHughes,AndrewEvans,Alice J.Manson,MarionHoffman,LesleySwinn,HilaryWatt,KailashBhatia,NiallQuinn,Andrew J.Lees.Mov. Disord. . 2005 (2)
- [4] Fluctuating parkinsonism: a pilot study of single afternoon dose of levodopa methyl ester[J] . Fabrizio Stocchi,Luca Barbato,Lucia Bramante,Giampietro Nordera,Laura Vacca,Stefano Ruggieri.Journal of Neurology . 1996 (5)
- [5] Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease .2 Olanow,CW,Kieburtz,K,Stern,M,Watts,R,Langston,JW,Guarnieri,M,Hubble,J. Arch Neurol . 2004